Shared decision making in mild to moderate dementia.

Award Number
Research for Patient Benefit
Status / Stage
2 April 2014 -
1 April 2017
Duration (calculated)
02 years 11 months
Funding Amount
Funder/Grant study page
Contracted Centre
Devon Partnership NHS Trust
Contracted Centre Webpage
Principal Investigator
Professor Rose McCabe
PI Contact
WHO Catergories
Models across the continuum of care
Disease Type
Mild Dementia
Moderate Dementia

CPEC Review Info
Reference ID64
ResearcherReside Team


Award NumberPB-PG-1111-26063
Status / StageCompleted
Start Date20140402
End Date20170401
Duration (calculated) 02 years 11 months
Funder/Grant study pageNIHR
Contracted CentreDevon Partnership NHS Trust
Contracted Centre Webpage
Funding Amount£252,191.00


Shared decision making has been shown to improve therapeutic alliance, treatment adherence, self-care and overall treatment outcomes1. However, in a condition such as dementia, which affects judgment and rational thinking, the involvement of a patient in making decisions may become increasingly difficult. Nonetheless, there is evidence that patients in the early stages of dementia prefer to participate in shared decisions. This is perhaps understandable given that key life-changing decisions often need to be made. The NICE guidelines for dementia state that patient involvement in decisions should be maximized. In addition, the guidelines make provisions for advance directives and lasting power of attorney covering health decisions. The early stages of dementia thus provide a window of opportunity to put these provisions in place for the future. However, there has been no research into the communication that takes place between professionals, patients and carers when making decisions in clinical practice. Aim: The aim of this project is to provide evidence on how to implement shared decision making in practice in mild to moderate dementia. Research Questions: 1) What are patients’ and carers’ preferences for, and experiences of, involvement in decision making? 2) How does the level of involvement of patients with mild to moderate dementia and their carers in shared decision-making vary depending on the decision? 3) What types of clinician communication facilitate shared decision making with patients and carers? Plan of Investigation: Sample size: 15 psychiatrists, 75 patients (5 patients from each psychiatrist to limit cluster effects) and 75 carers, will be recruited in Memory Clinics and other outpatient settings across NHS trusts. We will focus on secondary care as this is where decisions on management are frequently made. Patients will have a diagnosis of mild or moderate dementia with a Mini Mental State Examination score of 16 or above or other classification used in the clinical setting. Data collection and analysis: Patient and carer preferences for involvement in decision making will be assessed. Naturally occurring consultations involving the patient, carer and clinician(s) will be video recorded. Patient and carer satisfaction with decision making will be assessed after the consultation. Semi-structured interviews will be held with patients and carers. The interviews will address topics such as patient autonomy, positive and negative experiences of involvement in decisions, capacity to make decisions, obstacles to and facilitators of involvement. Focus groups with health care professionals will explore their experiences including challenges in involving patients and carers and strategies to overcome these within the constraints of practice. The consultations will be rated using the OPTION3 scale to quantify level of shared decision making. They will also be analysed using conversation analysis to identify communicative strategies that facilitate decision-making with patients and carers, particularly when patients and carers may have different preferences and views. The interviews and focus groups will be analysed using thematic analysis to identify high-level categories and subsequently themes. The statistical association between (i) preferences and level of shared decision making and (ii) level of shared decision making and patient and carer satisfaction will be analysed. Summary of potential benefits to patients and NHS: This study will benefit 0.75 million people with dementia, their carers and health care professionals in the NHS. Rather than identifying ideals for practice, we will identify evidence on how to involve patients and carers in decision making, within the constraints of busy everyday practice, different types of decisions and balancing different patient and carer preferences.


Aim: The aim of this project is to provide evidence on how to implement shared decision making in practice in mild to moderate dementia.